Implantable cardioverter defibrillators (ICDs) were found to have a beneficial effect on mortality in patients with chronic kidney disease (CKD). Mortality in patients with chronic kidney disease (CKD ...

Please provide your email address to receive an email when new articles are posted on . Patients with HF and CAD who increased their daily levels of physical activity after receiving an implantable ...

Among patients with advanced HFrEF, women, compared with men, are less likely to receive an implantable cardiac defibrillator. Women who have advanced heart failure with reduced ejection fraction ...

In a new publication from Cardiovascular Innovations and Applications; Yu Zhang, Wen-Long Dai, Can-Can Lin, Qiao-Yuan Li and Cheng-Jun Guo from Beijing Anzhen Hospital, Capital Medical University, ...

Please provide your email address to receive an email when new articles are posted on . Anxiety, depression and PTSD are common in patients with an implantable cardioverter defibrillator.

Small increases in daily physical activity are associated with a boost in 1-year survival in patients with heart failure and coronary disease who received an implantable cardioverter defibrillator ...

Early use of an implantable cardioverter-defibrillator (ICD) after primary coronary intervention lengthens survival in patients at high risk of death after ST-segment elevation myocardial infarction ...

PROFID EHRA, the first clinical trial seeking to challenge routine implantation of defibrillators in heart attack survivors with heart failure has just been launched. The European Society of ...

Receiving an implantable cardioverter-defibrillator (ICD) within the last 6 months does not appear to increase a patient’s risk of serious motor vehicle accidents, though some degree of hazard cannot ...